19 November 2019 - Aruvant, a clinical-stage gene therapy company focused on haematological conditions, announced on Tuesday that William Chou, MD has been appointed as chief executive officer.In this role, Dr Chou will lead Aruvant as the company pr...
19 November 2019 - BioArctic AB (STO: BIOAB), a Swedish research-based biopharmaceutical company, reported on Monday the results of an interim analysis of a phase 1/2 study of SC0806 in patients with complete spinal cord injury.Under this analysis, n...
19 November 2019 - Recipharm AB (STO:RECIB), a Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry, reported on Monday new financial targets for 2020, as the company has continued to grow.These new financial targ...
19 November 2019 - Cantargia AB (STO:CANTA), a biotechnology company that develops antibody-based treatments for life-threatening diseases, announced on Monday that new preclinical data on the antibody CAN04 is being presented at the 11th annual PEGS...
19 November 2019 - Vitrolife AB (STO:VITR), an international medical device company, announced on Monday the decision by Barbro Fridén to step down as a member of the board of directors of the company, reportedly due to other future opportunit...